METHODS	In a prospective , placebo-controlled , double-blind study , 500 patients were randomly allocated to treatment with n-3 FA ( Omacor , Pronova AS , Oslo , Norway ) 5.1 g/day or corn oil ( placebo ) starting at least two weeks prior to elective coronary angioplasty .\